Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma.
- Resource Type
- Article
- Source
- Investigational New Drugs; Jun2013, Vol. 31 Issue 3, p769-773, 5p
- Subject
ANTINEOPLASTIC agents ACADEMIC medical centers CLINICAL trials ENZYME-linked immunosorbent assay MELANOMA METASTASIS RESEARCH funding T-test (Statistics) DESCRIPTIVE statistics INVESTIGATIONAL drugs PHARMACODYNAMICS - Language
- ISSN
- 01676997